VHH Nanobody
Discovery & Development
Website temporarily unavailable
Following a recent PHP vulnerability, we have taken our website offline as a precaution. We have no indication that we are affected, and the site will return as soon as the proper safeguards are in place.
Smart VHH Nanobody Discovery
Cortalix offers VHH nanobody discovery and development services built on FC8™, our proprietary synthetic scaffold framework engineered from the ground up for clinical translation, powered by a sequential ribosomal display and phage display pipeline.
VHH Discovery via FC8™ Synthetic Libraries
Ribosomal display transitioning seamlessly into phage display. Animal-free, fast, and built for therapeutic development.
Immune VHH Discovery
Target-specific discovery from llama or alpaca immune libraries with naturally affinity-matured binders.
Lead Optimization
CDR grafting, humanization, stability profiling and affinity maturation.
Engineering & Conjugation
Fc-fusions, chelation, fluorophores, nanobody-drug-conjugates, linkers, toxins and multispecifics.
Preclinical Readiness
Expression, purification, in vitro profiling, radiopharmaceutical and CAR-T optimization, GMP transfer support.
Contact Us
Ready to eliminate your lead optimization bottleneck? Get in touch for a free scientific intake session, and we’ll map the fastest route to a clinical-ready VHH candidate. Our online contact form is unavailable during maintenance.
MediTech Center
L.J.Zielstraweg 1
9713 GX Groningen
The Netherlands
Cortalix is supported by
